Spyre Therapeutics Announces Grants of Inducement Awards
Summary
WALTHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the 'Company” or 'Spyre”), a clinical-stage biotechnology company ...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.